CN114028310A - 一种晒后修护凝露及其制备方法 - Google Patents
一种晒后修护凝露及其制备方法 Download PDFInfo
- Publication number
- CN114028310A CN114028310A CN202111495672.0A CN202111495672A CN114028310A CN 114028310 A CN114028310 A CN 114028310A CN 202111495672 A CN202111495672 A CN 202111495672A CN 114028310 A CN114028310 A CN 114028310A
- Authority
- CN
- China
- Prior art keywords
- parts
- erythritol
- sorbitol
- panthenol
- allantoin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000008439 repair process Effects 0.000 title claims description 26
- 238000002360 preparation method Methods 0.000 title description 4
- 238000001879 gelation Methods 0.000 title description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 claims abstract description 38
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims abstract description 36
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 25
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims abstract description 21
- 239000000600 sorbitol Substances 0.000 claims abstract description 21
- 239000004386 Erythritol Substances 0.000 claims abstract description 20
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 claims abstract description 20
- 229940009714 erythritol Drugs 0.000 claims abstract description 20
- 235000019414 erythritol Nutrition 0.000 claims abstract description 20
- -1 polydimethylsiloxane Polymers 0.000 claims abstract description 20
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 claims abstract description 19
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 claims abstract description 19
- 229960000458 allantoin Drugs 0.000 claims abstract description 19
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 claims abstract description 19
- 229940101267 panthenol Drugs 0.000 claims abstract description 19
- 235000020957 pantothenol Nutrition 0.000 claims abstract description 19
- 239000011619 pantothenol Substances 0.000 claims abstract description 19
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 claims abstract description 18
- 229940069521 aloe extract Drugs 0.000 claims abstract description 18
- 235000019437 butane-1,3-diol Nutrition 0.000 claims abstract description 18
- 239000004205 dimethyl polysiloxane Substances 0.000 claims abstract description 18
- 239000002773 nucleotide Substances 0.000 claims abstract description 18
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 18
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims abstract description 18
- 229920002385 Sodium hyaluronate Polymers 0.000 claims abstract description 17
- 239000008367 deionised water Substances 0.000 claims abstract description 17
- 229910021641 deionized water Inorganic materials 0.000 claims abstract description 17
- 229940064064 purslane extract Drugs 0.000 claims abstract description 17
- 229940010747 sodium hyaluronate Drugs 0.000 claims abstract description 17
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims abstract description 17
- 239000000463 material Substances 0.000 claims abstract description 13
- 230000001804 emulsifying effect Effects 0.000 claims abstract description 12
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims abstract description 11
- LXAHHHIGZXPRKQ-UHFFFAOYSA-N 5-fluoro-2-methylpyridine Chemical compound CC1=CC=C(F)C=N1 LXAHHHIGZXPRKQ-UHFFFAOYSA-N 0.000 claims abstract description 8
- 238000010438 heat treatment Methods 0.000 claims abstract description 7
- 235000010356 sorbitol Nutrition 0.000 claims abstract description 7
- 239000002562 thickening agent Substances 0.000 claims description 20
- 239000003755 preservative agent Substances 0.000 claims description 17
- 238000003756 stirring Methods 0.000 claims description 15
- 230000002335 preservative effect Effects 0.000 claims description 13
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 claims description 9
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 claims description 9
- 239000002994 raw material Substances 0.000 claims description 7
- 238000001816 cooling Methods 0.000 claims description 6
- 238000005086 pumping Methods 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 3
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 claims 4
- 230000001815 facial effect Effects 0.000 claims 1
- 230000008961 swelling Effects 0.000 abstract description 7
- 206010061218 Inflammation Diseases 0.000 abstract description 6
- 230000004054 inflammatory process Effects 0.000 abstract description 6
- 208000003251 Pruritus Diseases 0.000 abstract description 5
- 206010040844 Skin exfoliation Diseases 0.000 abstract description 5
- 230000035618 desquamation Effects 0.000 abstract description 5
- 208000024891 symptom Diseases 0.000 abstract description 5
- 206010006784 Burning sensation Diseases 0.000 abstract description 4
- 239000002537 cosmetic Substances 0.000 abstract description 4
- 230000036407 pain Effects 0.000 abstract description 4
- 230000035876 healing Effects 0.000 abstract description 3
- 241001116389 Aloe Species 0.000 abstract description 2
- 235000011399 aloe vera Nutrition 0.000 abstract description 2
- 210000001339 epidermal cell Anatomy 0.000 abstract description 2
- 230000008591 skin barrier function Effects 0.000 abstract description 2
- 229960002920 sorbitol Drugs 0.000 abstract description 2
- 230000008467 tissue growth Effects 0.000 abstract description 2
- 230000003712 anti-aging effect Effects 0.000 abstract 1
- 239000003963 antioxidant agent Substances 0.000 abstract 1
- 230000003078 antioxidant effect Effects 0.000 abstract 1
- 230000010261 cell growth Effects 0.000 abstract 1
- 230000001737 promoting effect Effects 0.000 abstract 1
- 230000004936 stimulating effect Effects 0.000 abstract 1
- 230000036561 sun exposure Effects 0.000 abstract 1
- TXFPEBPIARQUIG-UHFFFAOYSA-N 4'-hydroxyacetophenone Chemical compound CC(=O)C1=CC=C(O)C=C1 TXFPEBPIARQUIG-UHFFFAOYSA-N 0.000 description 16
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 6
- 240000000249 Morus alba Species 0.000 description 5
- 235000008708 Morus alba Nutrition 0.000 description 5
- 206010042674 Swelling Diseases 0.000 description 5
- 206010037660 Pyrexia Diseases 0.000 description 4
- 238000007599 discharging Methods 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 2
- BANXPJUEBPWEOT-UHFFFAOYSA-N 2-methyl-Pentadecane Chemical compound CCCCCCCCCCCCCC(C)C BANXPJUEBPWEOT-UHFFFAOYSA-N 0.000 description 2
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- 229940041616 menthol Drugs 0.000 description 2
- 229940015975 1,2-hexanediol Drugs 0.000 description 1
- PQUXFUBNSYCQAL-UHFFFAOYSA-N 1-(2,3-difluorophenyl)ethanone Chemical compound CC(=O)C1=CC=CC(F)=C1F PQUXFUBNSYCQAL-UHFFFAOYSA-N 0.000 description 1
- 229940043268 2,2,4,4,6,8,8-heptamethylnonane Drugs 0.000 description 1
- NCZPCONIKBICGS-UHFFFAOYSA-N 3-(2-ethylhexoxy)propane-1,2-diol Chemical compound CCCCC(CC)COCC(O)CO NCZPCONIKBICGS-UHFFFAOYSA-N 0.000 description 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 229920002884 Laureth 4 Polymers 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 244000234609 Portulaca oleracea Species 0.000 description 1
- 235000001855 Portulaca oleracea Nutrition 0.000 description 1
- NWGKJDSIEKMTRX-AAZCQSIUSA-N Sorbitan monooleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O NWGKJDSIEKMTRX-AAZCQSIUSA-N 0.000 description 1
- 206010042496 Sunburn Diseases 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- SFNALCNOMXIBKG-UHFFFAOYSA-N ethylene glycol monododecyl ether Chemical compound CCCCCCCCCCCCOCCO SFNALCNOMXIBKG-UHFFFAOYSA-N 0.000 description 1
- 229940100524 ethylhexylglycerin Drugs 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000003760 hair shine Effects 0.000 description 1
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 description 1
- KUVMKLCGXIYSNH-UHFFFAOYSA-N isopentadecane Natural products CCCCCCCCCCCCC(C)C KUVMKLCGXIYSNH-UHFFFAOYSA-N 0.000 description 1
- 229940061515 laureth-4 Drugs 0.000 description 1
- FQPSGWSUVKBHSU-UHFFFAOYSA-N methacrylamide Chemical compound CC(=C)C(N)=O FQPSGWSUVKBHSU-UHFFFAOYSA-N 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- RGUVUPQQFXCJFC-UHFFFAOYSA-N n-hydroxyoctanamide Chemical compound CCCCCCCC(=O)NO RGUVUPQQFXCJFC-UHFFFAOYSA-N 0.000 description 1
- 230000037311 normal skin Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229940047670 sodium acrylate Drugs 0.000 description 1
- 229950004959 sorbitan oleate Drugs 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229940104261 taurate Drugs 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/42—Amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/58—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur or phosphorus
- A61K8/585—Organosilicon compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/606—Nucleosides; Nucleotides; Nucleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/004—Aftersun preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Emergency Medicine (AREA)
- Cosmetics (AREA)
Abstract
一种晒后修复凝露，属于化妆品技术领域，由山梨糖醇、赤藓糖醇、芦荟提取物、马齿苋提取物、透明质酸钠、核苷酸、尿囊素、泛醇、环五硅氧烷、聚二甲基硅氧烷、1,3‑丁二醇、EDTA二钠和去离子水制成。去离子水加入水相锅中，加山梨糖醇、赤藓糖醇、EDTA二钠、泛醇、尿囊素、1,3‑丁二醇至溶解，加热保温。然后物料抽入乳化锅加环五硅氧烷和聚二甲基硅氧烷，均质乳化后，加入芦荟、马齿苋提取物、透明质酸钠和核苷酸，调节物料pH6.0。使皮肤保湿清凉滋润，舒缓晒后炎症反应消除红肿修复受损皮肤、促进组织生长、抗氧化抗衰老。降低灼热感、瘙痒、红肿、刺痛和脱屑等不适症状，刺激表皮细胞生长，促进皮肤屏障愈合。
Description
技术领域
本发明属于化妆品技术领域，特别是涉及一种晒后修复凝露及其制备方法。
背景技术
在日光强烈的时候，即使做了严密的防晒工作，也无法完全避免阳光的伤害。皮肤受到紫外线的照射后，晒伤处有明显灼热感、瘙痒、红肿、刺痛和脱屑等不适症状，且晒后的肌肤水分流失严重，屏障功能丧失，紫外线会促使细胞释放多种炎症介质，导致真皮血管扩张、组织水肿，激发炎症反应，令皮肤老化。
目前传统晒后修复产品在快速缓解皮肤发热方面，多采用酒精挥发降温和薄荷醇类物质来产生清凉的肤感，虽然解决皮肤发热的问题但是酒精却对日晒后皮肤造成了伤害，薄荷醇也加重了日晒过敏引起的炎症反应。
发明内容
基于此，本发明的一个目的是提供一种晒后修复凝露，本发明的另一个目的是提供其制备方法，是一种可以快速缓解皮肤发热，减少瘙痒、红肿、刺痛和脱屑等不适症状的晒后修复化妆品。
采用的技术方案是:
一种晒后修复凝露，主要是由山梨糖醇0.5-1.5份、赤藓糖醇2-5份、芦荟提取物3-7份、马齿苋提取物3-7份、透明质酸钠0.05-0.3份、核苷酸0.02-0.08份、尿囊素0.05-0.2份、泛醇1-3份、环五硅氧烷1-3份、聚二甲基硅氧烷0.5-1.5份、第一增稠剂Sepimax Zen(铵丙烯酰、甲基丙烯酰胺、月桂醇聚醚-4和甲基丙烯酸酯)0.55-1.25份、第二增稠剂SimugelEG(丙烯酸钠/丙烯酰二甲基牛磺酸钠共聚物、异十六烷、山梨醇酯80和山梨坦油酸酯)0.4-1.1份、1,3-丁二醇1-4份、EDTA二钠0.05-0.2份、去离子水70-80份、对羟基苯乙酮0.25-0.95份和桑普CHA150防腐剂(辛酰羟肟酸、1，2-己二醇和乙基己基甘油)0.2-0.7份制成的。
其中山梨糖醇、赤藓糖醇、芦荟提取物、马齿苋提取物、透明质酸钠、核苷酸、尿囊素和泛醇为功效成分，可以保湿消炎。
环五硅氧烷、聚二甲基硅氧烷、第一增稠剂Sepimax Zen、第二增稠剂Simugel EG、1,3-丁二醇、EDTA二钠和去离子水为基础成分。
对羟基苯乙酮(第一防腐剂)和桑普CHA150防腐剂(第二防腐剂)作为防腐剂。
其制作方法：取前述的原料：
A)将去离子水加入水相锅中，边搅拌边加入山梨糖醇和赤藓糖醇复配物、EDTA二钠、泛醇、尿囊素和1,3-丁二醇至完全溶解，加入第一增稠剂和第二增稠剂组合分散均匀后加热，加热至80～85℃，保温10min后备用。
B)将A)步骤得到的物料抽入乳化锅中，边搅拌边加入挥发性环五硅氧烷和聚二甲基硅氧烷，均质乳化3～10min后降温至40～45℃后，加入芦荟提取物、马齿苋提取物、透明质酸钠和核苷酸，调节物料pH值至6.0±0.5，加入防腐剂(对羟基苯乙酮和桑普CHA150防腐剂)，搅拌均匀，按QBT 2874-2007检测合格后出料，灌装。
其优点在于：
本品采用借助环五硅氧烷和水份挥发来降低皮肤表面温度并采用山梨糖醇与赤藓糖醇复配使皮肤感受到清凉的肤感。
本发明优选山梨糖醇搭配赤藓糖醇可在提供最佳保湿功效的同时带来清凉的肤感
本发明优选马齿苋提取物、芦荟提取物和尿囊素搭配舒缓晒后皮肤炎症反应，消除红肿，滋润干燥皮肤的功效。
本发明优选优选泛醇搭配核苷酸修复受损皮肤、促进组织生长、抗氧化抗衰老。
本发明晒后修护凝露能够快速有效的缓解皮肤发热，降低灼热感、瘙痒、红肿、刺痛和脱屑等不适症状，刺激表皮细胞生长，促进皮肤屏障愈合。
具体实施方式
实施例1
一种晒后修复凝露，主要是由环五硅氧烷2.5份、聚二甲基硅氧烷1份、山梨糖醇1份、赤藓糖醇4份、Sepimax Zen0.85份(第一增稠剂)、Simugel EG0.7份(第二增稠剂)、芦荟提取物5份、马齿苋提取物5份、1,3-丁二醇3份、尿囊素0.1份、泛醇2.5份、对羟基苯乙酮0.5份、EDTA二钠0.1份、透明质酸钠0.1份、核苷酸0.05份、去离子水73份和桑普CHA150防腐剂0.6份制成的。
所述的份均为质量份。
芦荟提取物(具体可为PORTULACA OLERACEA)、马齿苋提取物(具体可为ALOEYOHJYU MATSU EKISU)，聚二甲基硅氧烷为聚二甲基硅氧烷350。
本发明中采用的原料均为市售的化妆品原料，下述实施例中的方法均为本领域常规方法：
其制作方法为：
取本实施例中所述的比例的原料。
A)将去离子水加入水相锅中，边搅拌边加入山梨糖醇、赤藓糖醇、EDTA二钠、泛醇、尿囊素、1,3-丁二醇至完全溶解，加入第一增稠剂和第二增稠剂组合分散均匀后加热，加热至83℃，保温10min后备用。
B)将A)步骤得到的物料抽入乳化锅中，边搅拌边加入挥发性硅油环五硅氧烷和聚二甲基硅氧烷350，均质乳化5min后降温至42℃后，加入芦荟提取物、马齿苋提取物、透明质酸钠和核苷酸，调节物料pH6.0，加入防腐剂，搅拌均匀，按QBT 2874-2007检测合格后出料，灌装。
实施例2
一种晒后修复凝露，主要是由山梨糖醇0.5份、赤藓糖醇2份、芦荟提取物3份、马齿苋提取物3份、透明质酸钠0.05份、核苷酸0.02份、尿囊素0.05份、泛醇1份、环五硅氧烷1份、聚二甲基硅氧烷0.5份、第一增稠剂Sepimax Zen 0.55份、第二增稠剂Simugel EG 0.4份、1,3-丁二醇1份、EDTA二钠0.05份、去离子水70份、对羟基苯乙酮0.25份和桑普CHA150防腐剂0.2份制成的。
其制作方法为：
取本实施例中所述的比例的原料。
A)将去离子水加入水相锅中，边搅拌边加入山梨糖醇、赤藓糖醇、EDTA二钠、泛醇、尿囊素和1,3-丁二醇至完全溶解，加入第一增稠剂和第二增稠剂组合分散均匀后加热，加热至80℃，保温10min后备用。
B)将A)步骤得到的物料抽入乳化锅中，边搅拌边加入挥发性环五硅氧烷和聚二甲基硅氧烷350，均质乳化3min后降温至40℃后，加入芦荟提取物、马齿苋提取物、透明质酸钠和核苷酸，调节物料pH值至5.5，加入防腐剂(对羟基苯乙酮和桑普CHA150防腐剂)，搅拌均匀，按QBT 2874-2007检测合格后出料，灌装。
实施例3
一种晒后修复凝露，主要是由山梨糖醇1.5份、赤藓糖醇5份、芦荟提取物7份、马齿苋提取物7份、透明质酸钠0.3份、核苷酸0.08份、尿囊素0.2份、泛醇3份、环五硅氧烷3份、聚二甲基硅氧烷1.5份、第一增稠剂Sepimax Zen1.25份、第二增稠剂Simugel EG1.1份、1,3-丁二醇4份、EDTA二钠0.2份、去离子水80份、对羟基苯乙酮0.95份和桑普CHA150防腐剂0.7份制成的。
其制作方法为：
取本实施例中所述的比例的原料。
A)将去离子水加入水相锅中，边搅拌边加入山梨糖醇、赤藓糖醇、EDTA二钠、泛醇、尿囊素和1,3-丁二醇至完全溶解，加入第一增稠剂和第二增稠剂组合分散均匀后加热，加热至85℃，保温10min后备用。
B)将A)步骤得到的物料抽入乳化锅中，边搅拌边加入挥发性环五硅氧烷和聚二甲基硅氧烷，均质乳化10min后降温至45℃后，加入芦荟提取物、马齿苋提取物、透明质酸钠和核苷酸，调节物料pH值至6.5，加入防腐剂(对羟基苯乙酮和桑普CHA150防腐剂)，搅拌均匀，按QBT 2874-2007检测合格后出料，灌装。
测试例
实施例1所制备晒后修护凝露，分别经由23-54岁的男女各10例使用者，区域涂抹对比未使用晒后修护凝露，以5分制评价对功效有效率进行统计。单项功效有效率＝(单项功效20人该项功效评分之和除以100乘以)100％。可见本发明晒后晒后修护凝露可以有效缓解因日晒后受损皮肤的灼热感、瘙痒、红肿、脱屑等症状，能够有效促进受损皮肤愈合，恢复皮肤屏障正常。
Claims (7)
1.一种晒后修复凝露，其特征在于：主要是由山梨糖醇0.5-1.5份、赤藓糖醇2-5份、芦荟提取物3-7份、马齿苋提取物3-7份、透明质酸钠0.05-0.3份、核苷酸0.02-0.08份、尿囊素0.05-0.2份、泛醇1-3份、环五硅氧烷1-3份、聚二甲基硅氧烷0.5-1.5份、1,3-丁二醇1-4份、EDTA二钠0.05-0.2份和去离子水70-80份制成的。
2.根据权利要求1所述的一种晒后修复凝露，其特征在于：还有增稠剂0.95-2.35份和防腐剂0.45-1.65份。
3.根据权利要求1所述的一种晒后修复凝露，其特征在于：
一种晒后修复凝露，主要是由山梨糖醇0.5份、赤藓糖醇2份、芦荟提取物3份、马齿苋提取物3份、透明质酸钠0.05份、核苷酸0.02份、尿囊素0.05份、泛醇1份、环五硅氧烷1份、聚二甲基硅氧烷0.5份、1,3-丁二醇1份、EDTA二钠0.05份和去离子水70份。
4.根据权利要求1所述的一种晒后修复凝露，其特征在于：
一种晒后修复凝露，主要是由山梨糖醇1.5份、赤藓糖醇5份、芦荟提取物7份、马齿苋提取物7份、透明质酸钠0.3份、核苷酸0.08份、尿囊素0.2份、泛醇3份、环五硅氧烷3份、聚二甲基硅氧烷1.5份、1,3-丁二醇4份、EDTA二钠0.2份和去离子水80份。
5.根据权利要求1所述的一种晒后修复凝露，其特征在于：
一种晒后修复凝露，主要是由环五硅氧烷2.5份、聚二甲基硅氧烷1份、山梨糖醇1份、赤藓糖醇4份、芦荟提取物5份、马齿苋提取物5份、1,3-丁二醇3份、尿囊素0.1份、泛醇2.5份、EDTA二钠0.1份、透明质酸钠0.1份、核苷酸0.05份和去离子水73份。
6.一种晒后修复凝露的制作方法，其特征在于主要包括下列步骤：
A)准备原料：山梨糖醇0.5-1.5份、赤藓糖醇2-5份、芦荟提取物3-7份、马齿苋提取物3-7份、透明质酸钠0.05-0.3份、核苷酸0.02-0.08份、尿囊素0.05-0.2份、泛醇1-3份、环五硅氧烷1-3份、聚二甲基硅氧烷0.5-1.5份、1,3-丁二醇1-4份、EDTA二钠0.05-0.2份和去离子水70-80份。
B)将去离子水加入水相锅中，边搅拌边加入山梨糖醇、赤藓糖醇、EDTA二钠、泛醇、尿囊素和1,3-丁二醇至完全溶解，加热至80～85℃，保温10min后备用；
C)将A)步骤得到的物料抽入乳化锅中，边搅拌边加入挥发性环五硅氧烷和聚二甲基硅氧烷，均质乳化3～10min后降温至40～45℃后，加入芦荟提取物、马齿苋提取物、透明质酸钠和核苷酸，调节物料pH值至6.0±0.5，搅拌均匀。
7.根据权利要求6所述的一种晒后修复凝露的制作方法，其特征在于主要包括下列步骤：
在步骤B)加热之前，加入增稠剂0.95-2.35份；
在步骤C)调节物料pH值之后，加入防腐剂0.45-1.65份。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111495672.0A CN114028310A (zh) | 2021-12-09 | 2021-12-09 | 一种晒后修护凝露及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111495672.0A CN114028310A (zh) | 2021-12-09 | 2021-12-09 | 一种晒后修护凝露及其制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN114028310A true CN114028310A (zh) | 2022-02-11 |
Family
ID=80146519
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202111495672.0A Pending CN114028310A (zh) | 2021-12-09 | 2021-12-09 | 一种晒后修护凝露及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN114028310A (zh) |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003012453A (ja) * | 2001-06-29 | 2003-01-15 | Kose Corp | ゲル状化粧料 |
| CN104922056A (zh) * | 2015-05-29 | 2015-09-23 | 台山美环健芦荟制品有限公司 | 一种芦荟鲜汁凝胶及其制备方法和应用 |
| CN105168024A (zh) * | 2015-07-21 | 2015-12-23 | 刘振标 | 核酸美容液 |
| CN107303253A (zh) * | 2016-04-22 | 2017-10-31 | 长沙星工场生物科技有限公司 | 一种用于受损肌肤的修复剂及其制备方法 |
| CN107550806A (zh) * | 2017-08-17 | 2018-01-09 | 广东芭薇生物科技股份有限公司 | 一种水解小麦细粉、含水解小麦细粉的组合物及其应用 |
| CN108245468A (zh) * | 2018-03-30 | 2018-07-06 | 广州科盈化妆品有限公司 | 一种含有中药成分的激素脸修护精华及其制备方法 |
-
2021
- 2021-12-09 CN CN202111495672.0A patent/CN114028310A/zh active Pending
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003012453A (ja) * | 2001-06-29 | 2003-01-15 | Kose Corp | ゲル状化粧料 |
| CN104922056A (zh) * | 2015-05-29 | 2015-09-23 | 台山美环健芦荟制品有限公司 | 一种芦荟鲜汁凝胶及其制备方法和应用 |
| CN105168024A (zh) * | 2015-07-21 | 2015-12-23 | 刘振标 | 核酸美容液 |
| CN107303253A (zh) * | 2016-04-22 | 2017-10-31 | 长沙星工场生物科技有限公司 | 一种用于受损肌肤的修复剂及其制备方法 |
| CN107550806A (zh) * | 2017-08-17 | 2018-01-09 | 广东芭薇生物科技股份有限公司 | 一种水解小麦细粉、含水解小麦细粉的组合物及其应用 |
| CN108245468A (zh) * | 2018-03-30 | 2018-07-06 | 广州科盈化妆品有限公司 | 一种含有中药成分的激素脸修护精华及其制备方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN106726965B (zh) | 抗敏舒缓的护肤品组合物及其制备方法 | |
| CN111904906B (zh) | 修复肌肤屏障提高皮肤抵抗力的组合物及制备方法 | |
| CN111728907B (zh) | 一种舒缓抗敏组合物、其制备方法及在化妆品中的应用 | |
| CN114848541A (zh) | 一种抗衰祛皱组合物及其制备方法和化妆品及其制备方法 | |
| CN110123659B (zh) | 一种防脱发组合物及其在制备防脱发洗护产品中的应用 | |
| CN110742852A (zh) | 一种用于多效修复敏感肌肤的组合物及制备方法与用途 | |
| CN111973508A (zh) | 一种舒缓保湿的抗初老组合物 | |
| CN114748367A (zh) | 一种保湿修复精华及其制备方法 | |
| CN114129496A (zh) | 一种修护舒缓啫喱的配方及配置方法 | |
| CN105998617B (zh) | 一种具有舒缓老年皮肤瘙痒功效的外用中药提取物及制备方法和用途 | |
| CN111671692A (zh) | 一种祛痘组合物及其制备方法与应用 | |
| CN108379197B (zh) | 一种皮肤屏障修复保湿面膜及其制备方法 | |
| CN115006324A (zh) | 一种含神经酰胺np的滋养修护乳及其制备方法 | |
| CN114886811A (zh) | 一种修复敏感肌肤的组合物 | |
| CN112957290A (zh) | 一种保湿霜及其制备方法 | |
| CN114028310A (zh) | 一种晒后修护凝露及其制备方法 | |
| CN111135129B (zh) | 一种晒后修复组合物及其制备方法和化妆品 | |
| CN108158938A (zh) | 一种含美洲大蠊成分的祛痘面霜及其制备方法 | |
| CN109431881B (zh) | 一种防皮肤干裂的藏绵羊油 | |
| CN108542820B (zh) | 透皮吸收促进剂、护肤基质及其制备方法和应用 | |
| CN106667870A (zh) | 一种面膜 | |
| CN113797144A (zh) | 一种含铁皮石斛提取物的炭黑面膜精华液及其制备方法 | |
| CN111150696A (zh) | 一种晒后修复乳及其制备方法 | |
| CN110934785A (zh) | 一种美白保湿敏感肌肤用洗面奶及其制备方法 | |
| CN115137679B (zh) | 一种含有4-丁基间苯二酚的美白祛斑乳及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20220211 |